Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BOM/532523 stock hub

BOM/532523 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/532523is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

615.6B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/532523

In the news

Latest news · BOM/532523

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E52

P25 n/aP50 n/aP75 n/a

Trailing P/E101.9

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC3.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/532523 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

INR

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	16,420
Employees Change	105%
Employees Change Percent	0.64
Enterprise value	INR 782.5B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	INR 615.6B
Price	INR 381
Price currency	INR
Rev Per Employee	10,248,112.06x
Sic	2836
Symbol	bom/532523
Website	https://www.biocon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.98%
EV Earnings	129.5x
EV/EBIT	46.1x
EV/EBITDA	22.96x
EV/Sales	4.65x
Forward P/E	52.02x
P/B ratio	1.86x
P/E ratio	101.89x
P/S ratio	3.66x
PE Ratio10 Y	55.09x
PE Ratio3 Y	58.75x
PE Ratio5 Y	61.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.09%
EBITDA Margin	19.9%
Gross margin	60.87%
Gross Profit	INR 102.4B
Gross Profit Growth	13.52%
Gross Profit Growth Q	15.09%
Gross Profit Growth3 Y	18.91%
Gross Profit Growth5 Y	17.13%
Net Income	INR 6B
Net Income Growth	-24.88%
Net Income Growth Q	472.91%
Net Income Growth3 Y	15.9%
Net Income Growth5 Y	-0.21%
Pretax Margin	4.08%
Profit Margin	3.59%
Profit Per Employee	INR 367,966
Roa5y	2.76
Roe5y	6.82
ROIC	3.58
Roic5y	5.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.25%
Cagr15y	13.9%
Cagr1y	9.95%
Cagr20y	12.84%
Cagr3y	16.49%
Cagr5y	0.17%
Div CAGR10	0%
Div CAGR3	-30.66%
Div CAGR5	0%
EPS Growth	-29.06
EPS Growth Q	409.5
EPS Growth3 Y	13.67
EPS Growth5 Y	-1.38
Revenue Growth	13.99x
Revenue Growth Q	9.2x
Revenue Growth3 Y	19.71x
Revenue Growth5 Y	19.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 61B
Debt	INR 165.4B
Debt EBITDA	INR 4.85
Debt Equity	INR 0.5
Equity	INR 330.6B
Interest Coverage	1.77
Net Cash	INR -104.3B
Net Cash By Market Cap	INR -16.95
Net Debt EBITDA	INR 3.12
Net Debt Equity	INR 0.32
Tangible Book Value	INR -9.8B
Tangible Book Value Per Share	INR -7.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.94%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.5
Dividend Years	4
Dividend Yield	0.14%
Ex Div Date	2025-07-04
Last Dividend	INR 0.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	278.73%
1Y total return	9.94%
200-day SMA	374.1
3Y total return	58.07%
50-day SMA	370.8
50-day SMA vs 200-day SMA	50under200
5Y total return	0.87%
All Time High	487.7
All Time High Change	-21.97%
All Time High Date	2020-12-23
All Time Low	14.43
All Time Low Change	2,538.13%
All Time Low Date	2008-11-28
ATR	10.48
Ch YTD	-3.39
High	396.5
High52	425
High52 Date	2025-11-18
High52ch	-10.45%
Low	377.2
Low52	317.9
Low52 Date	2025-05-12
Low52ch	19.71%
Ma50ch	2.62%
Price vs 200-day SMA	1.72%
RSI	61.78
RSI Monthly	55.5
RSI Weekly	52.95
Sharpe ratio	0.66x
Sortino ratio	1.15
Total Return	-5.8%
Tr YTD	-3.39
Tr15y	604.53%
Tr1m	11.88%
Tr1w	5.59%
Tr3m	4.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 17B
Operating Income Growth	21.26
Operating Income Growth Q	-2.51
Operating Income Growth3 Y	13.96
Operating Income Growth5 Y	14.93
Operating margin	10.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	708,708,358%
Shares Insiders	46%
Shares Institutions	23.65%
Shares Qo Q	3.89%
Shares Yo Y	5.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	159,499.1x
Bv Per Share	207.9
Ch10y	272.7
Ch15y	536.1
Ch1m	11.88
Ch1w	5.59
Ch1y	9.8
Ch20y	857.1
Ch3m	4.2
Ch3y	56.73
Ch5y	-0.14
Ch6m	0.11
Change	-0.54%
Change From Open	0.49
Close	382.6
Days Gap	-1.02
Depreciation Amortization	16,506,250,000
Dollar Volume	141,915,086.6
Earnings Date	2026-05-07
EBIT	INR 17B
EBITDA	INR 33.5B
EPS	INR 4.76
F Score	1
Fiscal Year End	March
Founded	1,978
Graham Number	131.03723
Graham Upside	-65.57
Income Tax	INR 576M
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Last Split Date	2019-06-12
Last Split Type	Forward
Lynch Fair Value	INR 18.67
Lynch Upside	-95.09
Ma150	375.9
Ma150ch	1.24%
Ma20	360.2
Ma20ch	5.66%
Next Earnings Date	2026-05-14
Open	378.7
Payment Date	2025-08-22
Position In Range	17.4
Price Date	2026-05-08
Price EBITDA	INR 18.39
Relative Volume	2.34x
Revenue	168,274,000,000x
Tax By Revenue	0.34x
Tax Rate	8.38%
Tr20y	1,020.65%
Tr6m	0.11%
Volume	372,921

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BOM/532523 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

-5.8%

Next ex-dividend date: 2025-07-04

Performance

BOM/532523 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/532523?

Insider, institutional, and short-interest positioning.

Institutional ownership

+23.7%

Share of float held by funds and institutions

Insider ownership

+46.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.9%

Negative means the company is buying back shares.

Technical

BOM/532523 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.8

Neutral momentum band

Price vs 200-day MA

+1.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/532523

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/532523 stock rating?

bom/532523 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/532523 analysis?

The full report lives at /stocks/bom/532523/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/532523?

The latest report frames bom/532523 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/532523 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.